[HTML][HTML] Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review …
Background To overcome the several drawbacks of warfarin, non-vitamin K antagonist oral
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta …
Y Waranugraha, A Rizal, MFR Syaban… - The Egyptian Heart …, 2021 - europepmc.org
Background To overcome the several drawbacks of warfarin, non-vitamin K antagonist oral
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
[HTML][HTML] Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review …
Y Waranugraha, A Rizal, MFR Syaban… - The Egyptian Heart …, 2021 - tehj.springeropen.com
To overcome the several drawbacks of warfarin, non-vitamin K antagonist oral
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta …
Y Waranugraha, A Rizal… - The Egyptian heart …, 2021 - pubmed.ncbi.nlm.nih.gov
Background To overcome the several drawbacks of warfarin, non-vitamin K antagonist oral
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
[HTML][HTML] Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review …
Y Waranugraha, A Rizal, MFR Syaban… - The Egyptian Heart …, 2021 - ncbi.nlm.nih.gov
Background To overcome the several drawbacks of warfarin, non-vitamin K antagonist oral
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta …
Y Waranugraha, A Rizal, MFR Syaban… - The Egyptian Heart …, 2021 - search.proquest.com
Background To overcome the several drawbacks of warfarin, non-vitamin K antagonist oral
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …